Home » Posts tagged 'epo'
Tag Archives: epo
Last week in “Patenting AI/Machine Learning Inventions (Part 1)” Richard Lawrence and I discussed the challenges of patenting artificial intelligence and machine learning inventions. At the end of that video Richard promised me an example “with a dog”.
So, here’s part 2 of the video. Again, the video is provided with subtitles.
Mark Richardson 20 May 2020
Artificial Intelligence (AI) is appearing in every technology and industrial sector and has been accompanied by an increase in patent activity over recent years. In this video (subtitles available) I discuss the challenges of patenting artificial intelligence and machine learning inventions with Richard Lawrence of Keltie.
Part 2 of this video will be published next week on IPcopy.
Mark Richardson 13 May 2020
In response to the Coronavirus pandemic the EPO has adopted a number of special measures including the postponement until further notice of oral proceedings in examination and opposition proceedings unless they are scheduled to take place by video conference (or the applicant is willing to convert the proceedings into oral proceedings using video conference).
The use of video conferencing has therefore, for the moment at least, become the default for oral proceedings in front of the Examining Division. However, video conferencing during the Covid-19 pandemic brings a number of additional challenges compared to the normal use of the technology. (more…)
IP Offices around the world have announced special measures to take account of likely business disruption, not only to their own operations but also to those of their customers, from the Coronavirus outbreak. Here we summarise the measures of the EUIPO, EPO, WIPO, UKIPO and IPOI.
If you feel that your ability to respond to an IP deadline is affected by the Coronavirus situation then please contact your normal IP representative who will be able to advise on the options that may be available. It is important to note that the various IP Offices are applying different special measures and the extent of such special measures may not be immediately be apparent. Please also note that the special measures across the various IP Offices mentioned below are changing constantly so please check with your representative for the latest news.
The EPO will increase its fees with effect from 1 April 2020, with an increase of around 4% for most fees. The 4% increase is fairly consistent across the board with the notable exception that the EPO appeal fee for non-SMEs*, will increase by from €2255 to €2705, representing an increase of €450 or 20%.
Most fees are associated with particular payment deadline. The fee you pay is dictated by the EPO’s fee schedule** on the day of payment, rather than the fee schedule on the day of the deadline. This means that even if a relevant deadline falls on or after 1 April, you may be able to pay the fee early, on or before the 31 March, to take advantage of the current, lower fee rate. (more…)
It’s mid-January. Exam stress is rising. About two months from now, more than 2,000 candidates from close to 40 different countries will take part in either the EQE pre-examination or one or more of the four EQE main exams that are organised by the European Patent Office (EPO). These exams, especially the four main exams, are not easy. Only 2 in 5 candidates manage to pass all papers in their first attempt. Passing these exams is only possible with proper preparation. Following some courses is highly recommended for all papers. Thoroughly studying the (case) law and practicing a large number of old exams is unavoidable. (more…)
IPcopy recently attended an EPO presentation from the EPO’s Bioinformatics team on the subject of computer implemented inventions (CII) in biotech and healthcare and how to go about patenting such inventions.
This author works in Keltie’s software team and so is familiar with CII related inventions. Bioinformatics inventions however can sit somewhere between the biotech and software disciplines and so this presentation provided a handy insight for attorneys from either field into the subject area. (more…)
When entering the European regional phase from the PCT phase the choice of the international searching authority (EPO or non-EPO international searching authority) has an impact on the actions that are required shortly after regional phase entry and also an impact on the fees that are payable. This article provides a high level overview of the main points of difference. (more…)
This article compares amendment of patent applications before the USPTO and the European Patent Office (EPO), focussing on the differences in law and practice between these jurisdictions. Adaptation of a PCT application for regional phase entry in each jurisdiction is also discussed. References are made to the EPO Guidelines, which is the main source for European Patent Office practice. Some guidance is also provided on differences between claim interpretation in Europe and the US. (more…)
Further to our Brexit videos on designs and trade marks. Here’s IPcopy’s video summary of the impact of Brexit on patents.
4 April 2019